Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A EBIT

Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A (BDXA) currently reports a EBIT of $2.1B as of June 2026. That compares with $2.5B in the prior-year period — down 15.5% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's EBIT history and peer comparisons.

Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's EBIT decreased from $2.5B to $2.1B — a 15.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A's EBIT of $2.1B is lower than the Healthcare sector average of $22B. That is roughly 90.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A reported $2.1B in EBIT as of June 2026. That compares with $2.5B in the prior-year period — down 15.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $2.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A, and consider following BDXA for alerts when major investors trade the stock.